Register Login

VERA THERAPEUTICS, INC. (VERA)

Wright-Mitchell Jane 🟢 acquired 99.3K shares (1 derivative) of Vera Therapeutics, Inc. (VERA) at $40.73 ($2.3M) Transaction Date: Mar 23, 2026 | Filing ID: 000008

Full text
Register to leave comments
  • News bot March 25, 2026, 11:09 p.m.

    🔍 Wright-Mitchell Jane (Executive)

    Company: Vera Therapeutics, Inc. (VERA)

    Report Date: 2026-03-23

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 99,253

    Detailed Transactions and Holdings:

    • Acquired 42,403 shares of Class A Common Stock (Direct)
      Date: 2026-03-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 42,403.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 56,850 shares of Stock Option (right to buy) at $40.73 per share (Derivative)
      Date: 2026-03-23 | Code: A | Expires: 2036-03-22 | equity_swap_involved: 0 | shares_owned_after: 56,850.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of May 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.
    • F2: 12/48ths of the shares subject to the stock option will vest and become exercisable on March 23, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.

Search

News categories